Industry & Regulation

Seppic acquires Minasolve’s natural preservative platform

Seppic acquires natural preservatives specialist Minasolve
whitedaemon / pixabay

By Sophie Lindqvist

Seppic has expanded its natural-preservative portfolio by acquiring Belgian personal-care ingredient maker Minasolve, whose 12 patent families cover its conversion processes.

Founded in 2007, Minasolve has joined Seppic from Minafin Group. The Belgian company upcycles agricultural residues, including sugarcane bagasse, and transforms them into what Seppic describes as high-performance cosmetic ingredients. Financial terms of the transaction were not disclosed.

The acquisition adds Minasolve’s expertise in 100% bio-based glycols and naturally derived preservation boosters to Seppic’s offering, alongside its unique technological processes. For the French company, the stated aim is to consolidate its beauty-market position while meeting growing customer demand for natural and sustainable cosmetic ingredients.

What does this change for cosmetic formulators?

The immediate portfolio change is the addition of ingredients that Seppic says can help create natural cosmetic formulations without traditional preservatives. The company describes Minasolve as a natural-preservative specialist and positions its upcycling expertise as part of a longer-term commitment to green chemistry.

For a formulator, however, the announcement remains a portfolio statement rather than a product dossier. It does not identify individual booster or glycol products, concentrations, recommended use levels, compatible cosmetic bases, stability findings, challenge-test results, or substantiation for completed formulas. It also provides no comparative performance data against established preservative systems.

That gap matters when a finished product carries “natural” positioning. The source establishes where the ingredients come from and what Seppic intends to sell; it does not provide evidence showing how a particular ingredient performs in a final formulation.

For dermatology practices and skin-care professionals, any claims about a marketed product will still need assessment at that product level rather than inference from this acquisition.

Minasolve also brings a sustainability and corporate social responsibility profile. The announcement names ProTerra, COSMOS, NATRUE and USDA among its certifications, and EcoVadis Gold recognition for its environmental commitment and CSR approach.

These credentials support the provenance narrative Seppic wants to extend, although the source does not explain the scope of each certification or link a credential to a specific ingredient.

Minasolve relies on unique technological processes, and the announcement identifies 12 patent families protecting them. Seppic did not disclose patent numbers, jurisdictions, expiration dates or details about how those rights will be managed following the transaction.

“This acquisition demonstrates our ambition to position ourselves as a key player in the natural preservatives segment in cosmetics,” said Seppic CEO Virginie Cavalli.

“It also illustrates our long-term commitment to green chemistry in favour of developing ever more responsible ingredients,” Cavalli said.

At the business level, Seppic is adding a defined ingredient capability rather than a consumer beauty brand. The company says the acquisition expands its offer of naturally derived preservation boosters and helps it address growing requests for inputs that support natural formulations without traditional preservatives.

That is the transaction’s central commercial claim, and it comes directly from Seppic rather than independent formulation data.

The announcement does not quantify the acquired business. It provides no revenue, production-volume, employee, customer-retention, manufacturing-site or integration figures, and it gives no acquisition date or timetable for product commercialization. The practical gap is clear: formulators can see the capability Seppic has gained, but the source does not show its scale or when specific materials will reach the market.

Nor does the announcement make a clinical or dermatologic case. It cites no study population, skin endpoint, tolerability outcome, finished product or formulation-level evidence. The source supports a business and ingredient-development story, not an efficacy claim about a cosmetic or a treatment for a skin disease.

What to watch is equally concrete: whether Seppic launches named Minasolve-derived preservation products, publishes supporting formulation data and sets integration milestones. Those disclosures will determine whether the acquisition changes day-to-day development work for cosmetic formulators or remains mainly a strengthening of Seppic’s natural-ingredient platform.

Source: Personal Care Magazine

Share this article:

Sophie Lindqvist

Show full bio

Market editor covering people, launches and day-to-day practice in Clinical dermatology, inflammatory skin disease and biologics at Derm Field.

More from Sophie Lindqvist →

Related articles

« Previous articleNext article »